Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001819790-25-000071
Filing Date
2025-04-28
Accepted
2025-04-28 16:06:51
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A tarsuspharmaceuticalsinc.htm DEFA14A 5519
2 tarsuspharmaceuticalsinc001.jpg GRAPHIC 84465
3 tarsuspharmaceuticalsinc002.jpg GRAPHIC 168347
4 tarsuspharmaceuticalsinc003.jpg GRAPHIC 80348
  Complete submission text file 0001819790-25-000071.txt   465627
Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Filer) CIK: 0001819790 (see all company filings)

EIN.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39614 | Film No.: 25880309
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)